四川双马：关于控股子公司湖北健翔获得化学原料药上市申请批准的公告

Core Viewpoint - Sichuan Shuangma announced that its subsidiary, Hubei Jianxiang Biopharmaceutical Co., Ltd., has received the approval notice for the listing application of Acetyl-L-carnitine from the National Medical Products Administration [1] Group 1 - The approval is significant for the company as it expands its product offerings in the pharmaceutical sector [1] - The approval indicates a positive regulatory environment for the company's operations and potential growth in the biopharmaceutical market [1]